Comparison between Beta Drugs IPO and IRIS Business Services IPO.
Beta Drugs IPO is a SME Fixed Price IPO proposed to list at NSE SME while IRIS Business Services IPO is a SME Fixed Price proposed to list at BSE SME.
| Beta Drugs IPO | IRIS Business Services IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | NSE SME | BSE SME |
| Lead Managers | Pantomath Capital Advisors Pvt.Ltd. | Pantomath Capital Advisors Pvt.Ltd. |
| Registrar | MUFG Intime India Pvt.Ltd. | MUFG Intime India Pvt.Ltd. |
| Market Maker | Pantomath Stock Brokers Pvt.Ltd. | Asit C.Mehta Investment Interrmediates Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Beta Drugs IPO is up to ₹18.41 Cr whereas the issue size of the IRIS Business Services IPO is up to ₹15.18 Cr. The final issue price of Beta Drugs IPO is ₹85.00 per share and of IRIS Business Services IPO is ₹32.00 per share.
| Beta Drugs IPO | IRIS Business Services IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹85.00 per share | ₹32.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 1600 shares | 4000 shares |
| Fresh Issue Size | 21,66,400 shares | 47,44,000 shares |
| Fresh Issue Size (Amount) | up to ₹18.41 Cr | up to ₹15.18 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 21,66,400 shares | 47,44,000 shares |
| Issue Size Total (Amount) | up to ₹18.41 Cr | up to ₹15.18 Cr |
Beta Drugs IPO opens on Sep 29, 2017, while IRIS Business Services IPO opens on Sep 29, 2017. The closing date of Beta Drugs IPO and IRIS Business Services IPO is Oct 04, 2017, and Oct 04, 2017, respectively.
| Beta Drugs IPO | IRIS Business Services IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Sep 29, 2017 | Sep 29, 2017 |
| Issue Close | Oct 04, 2017 | Oct 04, 2017 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Oct 12, 2017 | Oct 11, 2017 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Beta Drugs IPO P/E ratio is , as compared to IRIS Business Services IPO P/E ratio of .
| Beta Drugs IPO | IRIS Business Services IPO | |
|---|---|---|
| Financials | ||
| Promoter Shareholding (Pre-Issue) | ||
| Promoter Shareholding (Post-Issue) | ||
| P/E Ratio | ||
| Market Cap | ||
| ROE | ||
| ROCE | ||
| Debt/Equity | ||
| EPS | ||
| RoNW |
In the Beta Drugs IPO Retail Individual Investors (RII) are offered 10,83,200 shares while in IRIS Business Services IPO retail investors are offered 10,83,200 shares. Qualified Institutional Buyers (QIB) are offered in Beta Drugs IPO and in IRIS Business Services IPO.
| Beta Drugs IPO | IRIS Business Services IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | 1,29,600 shares | 2,60,000 shares |
| QIB | ||
| NII | 10,83,200 shares | 23,72,000 shares |
| RII | 10,83,200 shares | 23,72,000 shares |
| Employee | ||
| Others | ||
| Total | 21,66,400 shares | 47,44,000 shares |
Beta Drugs IPO subscribed in total, whereas IRIS Business Services IPO subscribed .
| Beta Drugs IPO | IRIS Business Services IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | ||
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | ||
| Employee (times) | ||
| Other (times) | ||
| Total (times) |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
